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Role of the liver and the portal 
circulation in intestinal grafting 
Satoru Todo, Noriko Murase, Andreas Tzakis, 
and Thomas E Starzl 
Introduction 
Until recently. the intestine has been considered 
a forbidden ~Frgan in clinical transplantation. In 
the 25 years preceding 19H1). more than 15 such 
attempts were performed worldwide. but only 
with a few encouraging notations. I Most of the 
recipients died or lost their graft to refractory re-
jection. or to technical failures and infection. 
With the advent of FK 506. a potent immunosup-
pressive agent. we have shown that intestinal 
transplantation in humans alone or in combi-
nation with other viscera has become a practical 
reality.2.1.4.5 From May 1990 to September 19l)2. 
3D intestinal transplantations were performed in 
2l) patients at our centre (Table 10.1). Of these 
2l) recipients. 24 are currently alive. and 21 are 
completelv free trom total parenteral nutrition 
(TPN) from 2 to 25 postoperative months. 
Our clinical experience. along with our experi-
mental studies. has generated many questions 
aboU( previously accepted assumptions regarding 
intestinal transplantation. These include the pro-
curement and preservation of the intestinal graft. 
the monitoring and treatment of graft rejection. 
the occurrence of graft-versus-host disease 
(GYHD). and the long-term graft function. In 
addition. two important technical questions will 
be addressed: first. what method of venous out-
flow from the I!raft should be used. and second. 
what is the role of simultaneous liver transplanta-
tion in intestinal grafting'? 
Methods of clinical intestinal 
transplantation 
The methods of intestinal transplantation an: 
classified into three categories: isolated small 
bowel grafting. combined intestine and liver 
transplantation. and abdominal multivisceral 
transplantation. The isolated graft consists of the 
entire small bowel (except for a short segment 
distal to the ligament of Treiz and a segment 
proximal to the ileocecal valve) on a vascular 
pedicle of the superior mesenteric artery and the 
superior mesenteric vein (or skeletonized portal 
vein). Combined grafts contain both the liver and 
small bowel in continuity with the portal veIn and 
central arteries (the celiac axis and the superior 
mesenteric artery). Multivisceral grafts include 
the liver. stomach. pancreas. duode~um and small 
intestine (with optional proximal colon) with two 
nourishing arteries and the entire splanchnic 
venous svstem. The principles. steps. and the indi-
cations for each procedure in our clinical series 
are described elsewhere. 2•5.o 
Portal circulation in intestinal 
grafting 
Drainal!e of the intestinal venous effluent is prob-
lematic~ only with isolated intestinal transplanta-
tion. where- the venous outflow is either emptied 
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into the systemic system (mesocaval shunt) or 
transhepatically via an anastomosis to the native 
portal or superior mesenteric vein. A systemic 
shunt. bv which the intestinal venous olood flow 
is drained into the inferior vena cava (oypassing 
the portal vein and the liver). has been used fre-
quently for experimental and clinical intestinal 
transplantations occausc of tcchnical ease and 
safety. Several studies. however. have indicated 
that delivery of the venous outflow from the graft 
into the host superior mesenteric vein or portal 
vein. with consequent perfusion of the host liver. 
is superior for metaholic and immunologic 
reasons. 
Basic considerations 
Metabolic changes caused by splanchnic 
venous diversion 
Metaoolic changes that arc caused oy shunting 
intestinal venous blood in intestinal transplanta-
tion are similar to those seen after Eck's fistula 
out less pronounced; oecause with Eck's fistula 
there is a total diversion of the portal blood. as 
opposed to the partial diversion of intestinal 
effluent only. Under normal conditions. the portal 
vein constitutes a vital link for the enterohepatic 
circulation by which suostances such as choles-
terol. oile acids. biliruoin. urea. phospholipids. 
and lipid-soluble vitamins recirculate from the in-
testine to the liver to maintain homeostasis. For 
example. more than 95 per cent of the bile acid 
pool in the body (2-4 g/adult) is recirculated six 
times a day.x Of the I g/day of cholesterol that is 
secreted into bile from the liver. half is absorbed 
ov the enterocvtes and returned to the liver via 
. . 
the thoracic duct or the portal vein. along with an 
additional 0.5 g/day of cholesterol svnthesized hv 
the intestine. 'j Of the 4-6 g/day of urea synthe-
sized hy the liver. about one-fifth is degraded into 
ammonia in the intestine. and about 3.5 g/day of 
ammonia is re-absorhed and carried back through 
the portal vein to the liver. III As shown hy ma~y 
experiments and reVIewed elsewhere,1 if this 
enterohepatic CIrculation is interrupted by a porta-
caval shunt. significant metabolic abnormalities 
are induced or ~ggravatedK including elevation of 
plasma ammonia level and appearance of hepatic 
encephalopathy. 
Hepatic abnormality by portal diversion 
DiverSIon of the portal blood hy portacaval shunt 
has been shown to cause functional and structural 
aonormalities of the liver. 7 Marchioro and his 
associates. using a split (or partial) transposition 
model in dogs. showed hypertrophy in liver tissue 
perfused with splanchnic blood. and atrophy of 
the other tissues perfused hy systemic olood. II 
The venous cftluent from the non hepatic 
splanchnic organs that contains intestinal nutri-
ents and so-called hepatotrophic substances. 
especially endogenous insulin. 7.1; are essential for 
hepatocytes to maintain normal metaholism. 
architecture. and regenerative capacity. Besides 
insulin. these hepatotrophic factors include other 
hormones and growth factors that originate in vis-
ceral organs other than the pancreas. 7 These arc 
now being studied systematically." 
Immunologic modulation after antigen infusion 
into portal vein 
The liver. located hetween the gastrointestinal 
tract and the systemic circulation. serves as a filter 
to eliminate hacteria. endotoxins. carcinogens. 
and toxic suostances absorhed into the portal 
system. Similarly. this filtration has been postu-
lated to modulate transplantation antigen to offer 
immunologic protection to a variety of homo-
grafts. f~ When the venous return from the grafts 
is drained into the portal vein rather than into the 
systemic vein. or the antigen is injected into the 
portal vein before transplant. significant pro-
longation of graft survival has heen claimed with 
hearts.'; kidneys, 1(, parathyroid. I? and pancreas 
islets. f~ However. when this effect is compared 
among different species and strains. striking im-
munologic amelioration by antigen Inoculation 
into the portal system has been restricted princi-
pally to mice and rats of low-responder strain 
combinations. fDfK~l Mazzoni et al.. who compared 
the two venous drainage methods. systemic versus 
portal. could not demonstrate any prolongation 
of graft survival after kidney transplantation in 
dogs and pigs.;1 contrary to his earlier ohserva-
tionsll> in the same porcine model. 
Experimental findings with intestinal 
transplantation 
Rat experiments 
Results on the influence by different venous diver-
sions (systemic circulation versus portal circu-
lation) in intestinal transplantation have been 
conflicting. In an isograft model. which eliminates 
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Table 10.1 Clinical features of intestinal transplant recipients at the Universitv of Pittsburgh 
PI. 
7 
II 
10 
11 
12 
I.I 
14 
15 
16 
17 
IX 
III 
21 
24 
25 
26 
27 
2') 
Sex Indication Transplantation 
.11.1 
3.2 
26.7 
2.X 
0.6 
1.1 
1.7 
21 
10.2 
25 
2(1 
4.2 
F 
M 
F 
F 
M 
0.75 M 
0.5 
3l.5 
1'1.1 
M 
F 
M 
F 
Date Graftt 
(iun shOI wound 5/2190 
Necrotizing cnierocoillis 7/24190 
SMA thromhosis R/]/90 
Gastroschisis 11124190 
I ntesllnal atresia 
Intestinal atresi" 
Volvulus 
Volvulus 
Traflic "ccldcnt 
CA & SMA thrombosis 
Microvillus inciUS101l 
disease 
I ntestinal atresia 
Crohn's disease 
Desmoid tumor 
Crohn's disease 
Pseudo·obstruction 
Crohn's dlseasc 
Crohn's disease 
Necrotizing enterocolitis 
Desmoid tumor 
CA & SMA thromboSIS 
Traffic aCCident 
Gastroschisis 
Gastroschisis 
Microvillus inclusion 
disease 
GastroschiSIS 
CA & SMA thromhosis 
Traffic accident 
SMA thrombosis 
3/24191 
R/9/91 
XII 0191 
XII 2m 
Xl2 I/lJ I 
I0/14/'!1 
10/31")1 
12mNI 
12J2/l1lJl 
2/3192 
3/4/lJ2 
3/6192 
31121'J2 
3/2/l192 
4/]()/92 
5/25/lJ2 
512XN2 
01719"2 
0110/92 
7/14fl)2 
7121192 
71:.7192 
RI 1 2192 
R/14/92 
9nt92 
S8 
SB 
SB/L 
SB/L 
SB/L 
SB/L 
SB/L 
SB/L 
SB/L 
SB/L 
MV 
SB 
SB 
SB 
SB 
S8 
SB 
SB 
SB/L 
SB/L 
SB/L 
MV 
S8 
SB/L 
SB/L 
SB/L 
SB/L 
MV 
SB/L 
SB/L 
'SurYIvallll days as of 10/21/1)2 
tSB = Small bowel: SB/L = Small howel-liver: MN = Multivisceral 
Patient 
survival· 
776 
>X20 
>XIO 
>697 
3X5 
>4JX 
>430 
>427 
>373 
>356 
>301 
>29X 
>261 
>231 
>229 
>223 
>207 
70 
>149 
>140 
>130 
>133 
29 
>92 
>86 
>70 
>oR 
>44 
Graft 
survival· 
oM 
71 
>R2(1 
>XIO 
>097 
3X5 
>43X 
>430 
>427 
>373 
>356 
>301 
>29X 
239 
>231 
>229 
>223 
>207 
70 
>149 
>140 
>130 
>133 
29 
>92 
>80 
>70 
>6X 
>44 
TPN 
status 
Current 
location 
Graft removed 
Retransplanted and 
died 
Free 
Frel' 
Free 
Died 
Died 
Free 
Free 
Partial 
Parti,,1 
Free 
Free 
Free 
Homl' 
Home 
Home 
Homl' 
Home 
Home 
Home 
Home 
Hospital 
Home 
Graft removed 
Free Home 
Free Home 
Free Home 
Free Home 
Died. Multiorgan 
failure and sepsis 
Free 
Free 
Free 
Free 
Died 
Free 
Free 
Free 
Free 
Free 
Home 
Home 
Home 
Home 
Home 
Home 
Hospital 
Home 
Hospital 
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the participation of immunologic components in 
transplantation. Schraut et ai. 22 and Koltun et ai. 2' 
found that rats receiving an intestinal graft with a 
systemic shunt had reduced bodv weight. mod-
erate liver atrophy. increased ammonia levels. 
and abnormal amino acid profiles. Shaffer et ai.. 
however. could not sec anv difference in these 
measures during 6 weeks li pair-feeding. 24 
Using a heterotopic allotransplantation model 
from (LEW/BN)/FI donors to LEW recipients. 
Schraut et ai. and others studied the difference in 
immunologic responses between the two drainage 
methodsKO~K~EIKeT Without immunosuppression. 
mean survival with a mesenteric-systemic shunt 
was 10.5 days. while it was significantly prolonged 
to n.ll days in animals with portal intestinal 
drainage. Portal drainage appeared to suppress 
the early onset of acute rejection. but enhanced 
the development of chronic rejection. Although 
these rindings supported the theory that transhep-
atic drainage of venous outflow mitigates the im-
mune response to the intestinal graft. they were 
not confirmed in the experiment by Shaffer et ai.. 
using the same strain combination and surgical 
technique. 24 Neither group could find any im-
munologic benefit by transhepatic portal drainage 
when the intestinal transplantation was performed 
with a GVHD strain combination. LEW to 
(LEW/BN) Fl. or with a bi-directional strain 
combination of BN to LEW.24.z7 
However. because animal survival is deter-
mined by the function of the recipient's own smail 
bowel in the heterotopic intestinal transplantation 
model used by these investigators. we used an 
orthotopic transplantation technique with the BN 
to LEW strain combination. eX When no immuno-
suppression was given. both group animals died 
of intestinal rejection with median survival time 
of 12.0 days in portal drainage animals and 10.5 
days in systemic shunt animals (not significant). 
When a moderate dose of FK 506 was adminis-
tered for two weeks postoperatively. all of the 
animals except for one in each group survived 
for more than 100 days. Although long-surviving 
animals from both groups showed similar histo-
pathologic changes of chronic graft rejection. 
postoperative weight gain was superior when the 
venous drainage was transportal. These findings 
suggested that portal drainage of the intestinal 
graft offers better metabolic conditions. but pro-
vides little immunologic benefit. 
Large animal experiments 
Conflicting results also have been reported in 
large animal experiments. Using an autotrans-
plantation model in dogs. Raju et al. studied the 
nutritional status. body weight. nitrogen balance. 
d-xylose and fat absorption. serum iron. and 
serum albumin for as long as one year. e'l Most of 
these measures except for bodv weight and 
nitrogen balance were abnormal with both portal 
and systemic venous drainage methods. but more 
severely so in the animals reconstructed with a 
mesenteric-systemic shunt. However. no such 
metabolic distinction was seen between the two 
drainage methods in the pig experiments of 
Kaneko et aL·lI) In addition, the latter authors 
could not prove any prolongation of animal sur-
vival of portal drainage in allotransplantation ex-
periments under treatment with cyclosporin. 
Clinical experience 
Historical cases 
Detailed descriptions of operative procedures and 
postoperative courses of II patients receiving iso-
lated intestinal grafts under azathioprine or cyclo-
sporin have been reported by others in the 
literature (Table 10.2) .11-41 The arterial recon-
struction in these cases was made bv using three 
vessels: the infrarenal abdominal aorta. the iliac 
artery, and the superior mesenteric artery. The 
preferred outflow sites for intestinal venous 
drainage were the iliac vein and the inferior vena 
cava. but the left renal vein. the superior mesen-
teric vein and the portal vein were also used in 
three cases. I n the selection of the recipient vein 
for these reconstructions. technical feasibilitv was 
the single most determining factor. For example. 
Alican anastomosed the graft vein to the left renal 
vein of the recipient since both the inferior vena 
cava and the iliac vein were completely throm-
bosed by his patient's underlying disease. 
It was not practical to compare the performance 
of systemic versus portal drainage methods in 
these clinical cases because most of the grafts 
failed shortly after intestinal transplantation. 
However. it is noteworthy that two recipients 
whose graft venous flow (one from a segment of 
living donor intestine and the other a cadaver in-
testine) was drained into the systemic circulation. 
are currently alive for more than 3.5 and 4 years. 
respectively. with no evidence of metabolic 
abnormality.wAI One of the patients, a 15 month-
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Table 10.2 Historical cases of isolated intestinal transplantatton 
Reference Patient's Reconstruction 
Year I nvesti~Utor Number A~e Indication Donor Graft Artery Vein 
A. Azathioprine era 
1967 Lillehcl 31 ~S SMV thrombosis Cadavenc Whole Iliac Iliac 
I%X Okumura 32 P~ SMA thrombosis Cadaveric Partial Iliac Iliac 
I%l) Olivier 33 35 Gardner"s Cadaveric Whole SMA SMV 
syndrome 
1%1} Alliean ]-1 X Volvulus Living Partial Aorta Left Renal 
197() Fortner 35 37 Gardner's Living Partial Iliac Iliac 
syndromc 
B, Cyclosporine era 
19H5 Cohen 36 26 Gardner's Cadaveric Wholc Aorta Ive 
svndrome 
19R7 Goulet 37 9 Volvulus Cadaveric Partial Aorta IVC 
19HH Hansmann 31' :; Volvulus Living Partial Iliac Iliac 
19RR Deitz 39 ~O SMV thromhosis Living Partial Iliac Iliac 
19HR Grant ~EF X Neuromyopathy Cadaveric Wholc Aorta Portal 
191'9 Goulet ~l 0,4 Volvulus 
old girl. who was underdeveloped at the time of 
transplantation. is now normal for both height 
and weight.-l ' Thus. the problem of venous 
drainage in clinical intestinal transplantation may 
have less influence on metabolism and immu-
nology than in animal experiments, 
OUf experience 
We tried to drain the intestine physiologically 
through the host portal vein in our isolated intes-
tinal recipients, The predicted technical diffi-
culties were minimized bv using a mesenteric 
piggy-back procedure, -12 With thi~ approach. the 
portal vein is found in the subhepatic triad and 
dissected to obtain enough length for its side to 
accept the end of the superior mesenteric vein or 
the portal vein of the graft. This has been feasible 
even when the patients have had multiple laparot-
omies and adhesions. Of the':) recipients in whom 
an isolated graft was transplanted. intestinal 
transplantation was successfully performed with 
this technique in 7. In the remaining two. the re-
cipient superior mesenteric vein which was dis-
sected out of the scar inferior to the transverse 
mesocolon was used to receive the graft superior 
mesenteric vein end-to-end. The inferior vena 
cava for mesenteric outflow was used on one 
occasion for retransplantation of a patient who had 
a gunshot wound at the hepatic hilum and who 
Cadaveric Wholc Aorta Ive 
lost the first graft to chronic rejection. The venous 
drainage for the first graft had been via an end-
to-end anastomosis to the recipient's superior 
mesenteric vein. There were no technical compli-
cations nor metabolic problems in any of these 
cases. 
Liver in intestinal grafting 
There are numerous experiments demonstrating 
that the concomitantly transplanted liver induces 
immunologic protection. or tolerance. to other 
organ allografts procured from the same donor. 
Because of severe graft rejection that develops in 
experimental and clinical intestinal transplanta-
tion. Grant et al. proposed that the liver should 
be transplanted with the intestinal graft to miti-
gate graft rejection. even if the recipient has 
normal liver functionK~Kl In contrast. patients who 
have intestinal failure and liver disease. as compli-
cation of TPN or inborn errors. require combined 
intestine and liver transplant. If the intestinal 
failure is from the thrombotic problems that in-
volve both the celiac axis and the superior mesen-
teric artery or if the indication is a centrally 
located tumour. abdominal multivisceral trans-
plantation may be chosen as the method of sur-
gical treatment. 
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Basic considerations 
Hepatic tolerogenicity 
Evidence of hepatic tolerogenicity for other tis-
sues and organs from the same donor was first 
noted in our original canine multivisceral experi-
ments:1-l The concept was fully developed by 
Caine in IlJ6'i who showed indefinite pro-
longation of kidney and skin graft survival in pigs 
receiving concomitant liver transplantation. 4, This 
finding was confirmed later by Kamada and 
others. using rat liver transplantation with various 
strain combinations. 4h The mechanism of hepatic 
tolerogenicity is still unclear, but many explan-
ations have been proposed. such as clonal de-
letion of cytotoxic T cells, production of antibody 
to class II MHC, liver enzymes inactivating 
antigen. antigen alteration by Kuppfer cells. inhi-
bition of immune stimulation. and production of 
soluble donor class I antigen. However. the recent 
demonstration that migratorv tissue leukocvtes 
from the liver create a state of microchimerism in 
the recipient has provided an alternative and 
more likely explanation. 47.""'4'1 
Microchimerism 
We now believe that the development of two-way 
cell traffic. between the graft and the recipient. 
leading to long-lasting systemic microchimerism 
is the reason for hepatic tolerance as well as toler-
ance induced by other organs including the 
intestine. During histoimmunologic studies of 
rats receiving C multivisceral t;ansplantation. 
Murase et al. found that the cells in the lymphoid 
and non-lymphoid tissues of the grafts were re-
placed by recipient-derived cells as early as 12 
days after transplant.:ill a finding also seen by 
Arnaud-Battandier in pigs. II Not only did re-
cipient spindle-shaped dendritic cells. positive for 
anti-recipient-Ia monoclonal antibody. repopu-
late into the graft. but donor dendritic cells 
migrated from the graft and resided in tissues 
of the recipient..,2 After intestinal transplantation. 
donor-derived cells in the spleen. mesenteric 
lymph nodes and peripheral blood in the recipient 
accounted approximately for 10-15 per cent of 
cells at I week. 5-10 per cent at 3 weeks and 5 
per cent at 4 to h weeks. 51 Similarlv. Iwaki et al. 
described two-way cell traffic phenomenon in the 
patients receiving intestinal transplantation. 5., Ten 
to 15 per cent of peripheral blood cells in the 
human recipients were of donor phenotype for 
several weeks after transplantation. and lymphoid 
tissues of the intestinal graft were completelv re-
populated by recipient-derived cells within 45-90 
days after transplantation. Although Grant attri-
buted the presence of donor cells in recipient cir-
culation to transient GVHD.4\ no GVHD was 
seen in Iwaki's cases and we now realize that this 
occurs in all cases. 
The two-way cell traffic phenomenon or micro-
chimerism is not unique to intestinal transplanta-
tion. but is also seen after transplantation of other 
organs in both experimental and clinical settings; 
donor-derived dendritic cells were demonstrated 
in the peripheral blood and tissues of patients who 
underwent hepatic or renal transplantation 10 to 
2'i years previously. Thus. development of sys-
temic chimerism seems to be an obligatory step 
for successful transplantation and for !!raft accept-
ance or tolerance in all whole organs. These find-
ings suggest that the liver exhibits more 
pronounced tolerogenicity because it contains 
abundant Iymphoreticular cells and has a greater 
capacity to induce systemic microchimerism than 
other organs. Donor-specific soluble class I anti-
gens that are detectable in systemic circulation 
after liver transplantation have been attributed to 
hepatocytes.:\4 but these antigens undoubtedly arc 
secreted in large part by these pcripheralized 
donor-derived cells of macrophage/monocyte lin-
eage. 
Experimental findings with intestinal 
transplantation 
Rat experiments 
Protection by the liver of intestinal graft rejection 
has been studied by Grant's group in Canada and 
Goulet's group in France. 5551>.57 Grant et al. 
demonstrated that when the LEW intestine was 
transplanted into DA rats without immuno-
suppression. all of the rats developed histologic 
acute rejection at 7 days, and had full-thickness 
necrosis of the intestinal wall at 14 days at sacri-
fice. However, these changes were not observed 
when they transplanted the intestine and liver sim-
ultaneously. Combined graft recipients had sup-
pressed function of both T and B cells. Goulet 
and his associates tried to induce tolerance of the 
intestine by transplanting the intestine 14 days 
after liver transplantation from DA rats to PVD 
rats.57 Bv this method. five of the six combined 
graft animals lived for more than 150 days without 
any immunosuppression. whereas all of the iso-
lated intestine recipients died of rejection with 
median animal survival of 7.6 days. 
However, the induction of immunologic protec-
tion hy the liver appears to be limited to particular 
strain comhinatlOns and to the timing of intestinal 
grafting after liver transplantation. When the 
comhined grafts from DA rats were transplanted 
simultaneously,'" not separately, into PVG recipi-
ents (a low responder). the intestine did not he-
come tolerant: rather. the PVG recipients died 
within I} days after transplant from lethal GVHD. 
Neither the liver nor intestine of the combined 
graft animals showed rejection. Animals receiving 
an isolated graft of this combination died by rejec-
tion with mean survival of 1X.6 davs. When a BN 
to LEW combination (a moderate responder) was 
used. animals that received a combined graft died 
either of GVHD or liver re,jection with mean sur-
vival of 12.6 days, Isolated intestinal graft recipi-
ents with this comhination died of rejection with 
a mean survival time of 12,X days. Finally. when 
an ACI to LEW comhination (a high responder) 
was used. J out of the 5 combined graft animals 
died within 13 days from severe hepatic rejection 
hut with normal intestine. Isolated graft rats in 
this combination died of rejection with mean sur-
vival of 12 days. 
Instead of comhined intestine and liver grafts. 
we studied immunologic protection hy the liver 
using a multivisceral transplantation model in BN 
to LEW strain combination,"1I5K The results of 
multivisceral transplantation were compared with 
those with isolated intestine or liver transplanta-
tion alone. Without immunosuppression. isolated 
liver recipients survived indefinitely. whereas ani-
mals receiving multiple organs or an isolated in-
testine lived only for 10 to 13 davs. Both groups 
of ammals had severe and similar intestinal rejec-
tion hv histopathologic study. Thus. immunologic 
protection by the liver to the companion intestine 
was not demonstrated in this model. When a 14-
dav course treatment with low-dose FK 506 was 
given. most of the animals were able to survive 
for more than a 100 days in all three transplant 
groupS.)1I However. intestinal rejection detected 
by histologic analysis of sacrificed animals was 
worse in animals with an isolated intestine than in 
animals with a composite of multivisceral grafts. 
Bodv weight gain was suppressed in isolated graft 
animals compared with the multivisceral group. 
These findings indicate that the liver in the multi-
visceral graft provides an immunologic advantage 
to the companion intestine under low-dose FK 
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SOb treatment. However. when immunosuppres-
sion was augmented to a high-dose 14-day course 
therapy. the difference hetween the multiviseeral 
group and the isolated intestine group decreased. 
When hoth groups of animals were treated hy 
high-dose FK 50t) for 14 days and with weekly 
supplementation. there was no difference in hody 
weight gain or histologic severity of intestinal re' 
jection. Hepatic tolerogenicity that is barely seen 
with low-dose immunosuppression hecame insig-
nificant when high-dose FK SOt) was administered. 
Large animal experiments 
The multivisceral transplant operation was de-
scrihed in dogs more than 30 years ago. +I Of the 
3X animals submitted to this operation in 1951} 
without immunosuppression. only 5 lived for 5.5 
to 9 days. Histologic studies revealed attenuation 
of liver graft rejection in these animals compared 
with animals that underwent liver transplantation 
alone. suggesting mitigation of the rejection pro-
cess. There also was little evidence of rejection in 
the bowel and other organs of the multivisceral 
graft. prompting the conclusion that here also re-
jection was attenuated. On the other hand. strong 
histopathologic evidence of GVH reaction was 
found in the bone marrow. lungs. and other 
organs of the animals receiving multivisceral 
organs than in animals receiving isolated liver 
grafts. 
Clinical experience 
Historical cases 
In November 1987. a child in Pittsburgh who re-
ceived a multivisceral graft became the first re-
cipient of an intestine that provided nutritional 
function. The patient died after 6 months of a B 
cell lymphoma. but during life there was little or 
no evidence of rejection - either of the liver or of 
the other viscera. 5<; Immunosuppression was with 
cyclosporin. low doses of prednisone. and OKT3. 
More decisive clinical evidence of amelioration 
of intestinal rejection by a hepatic graft was sub-
sequently described by Grant et al. in a 41 year-
old woman. who lost her small intestine by 
superior mesenteric artery thrombosis from 
antithrombin-III deficiency.4., She received a com-
bined liver and small bowel allograft under im-
munosuppression with cyclosporin. steroids and 
azathioprine. The donor was treated hy OKT3 
before procurement. After surgery. she de-
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veloped mild GVHD on the eleventh postopera-
tIve day. which subsided spontaneously. During 
the ninth postoperative week. she developed mild 
intestmal rejection which was easily treated by 
steroid tapering and OKT3. There was no other 
episode of rejection in either of the grafts there-
after. The patient has been doing well for the past 
4 years. nutritionally supported by an unlimited 
oral diet. The benign postoperative course in this 
historically important case was in clear contrast 
to this group's previous experiences with clinical 
intestinal transplantation. suggesting that the co-
existing liver graft ameliorated intestinal rejec-
tion. However. a patient who received a 
combined graft in Wisconsin died after 52 days by 
rejection.'" and a second patient treated by us 
with multivisceral transplantation under cyclo-
sporin suffered the same fate as well as a dissemi-
nated Iymphoma. hl 
Our experience 
We only perform a combined intestine and liver 
transplant on patients who have end-stage organ 
failure in both the intestine and liver. Of the 17 
recipients receiving combined grafts at our centre 
under FK 506-based immunosuppression. all had 
cholestatic liver disease related to long-term 
hyperalimentation. with a median preoperative 
serum bilirubin level of 18.5 mg/dl. ranging from 
2.3 mg/dl to 50.5 mg/dl. Most of these patients 
had evident portal hypertension and hyperspl-
enism. Nine patients who had intestinal failure 
with normal liver function were transplanted with 
the intestine alone. Twelve out of the 17 com-
bined graft recipients and all of the isolated graft 
recipients were operated on between May 1990 
amI June 1992. The survival. postoperative 
course. and the incidence and severi ty of graft 
rejection with a minimum follow-up for three 
months were computed and compared to deter-
mine the performance of respective surgical pro-
cedures (Table 1O.3).nZ.nl 
Nine of the 12 combined graft recipients are 
currently alive. There were 3 deaths: 2 from septic 
complications related to technical problems and I 
from postoperative lymphoproliferative disease. 
Patient and graft survival was 75 per cent (9/12). 
Of the 9 isolated graft recipients. one patient died 
from sepsis 71 days after retransplantation and 
removal of the primary graft which had been de-
stroyed by chronic rejection after 23 months. 
Another patient required graft removal and re-
Table 10.3 Comparison of intestmal graft 
performance 
Isolated small Combined small 
bowel bowel and liver 
Number 
Patient t) i~ 
Graft 10 12 
Survival* 
Patient R (90%) \) (75':; ) 
Graft 7 (70o/c) 9 (75':; ) 
leu Stav. davs 6 (4-\4) .1 (.1-.1()Ol 
Hospital Stay'. 79 (33-\59) X2 (2.1-320) 
days 
Readmission. I (1-7) 2.5 (O-9l 
times 
Stop TPN. days 30 (19-\13) X.1.5 (44-.1.10) 
Rejectlon 
Episodes 
Intestine 10(90%) 10 (RVi;) 
Current Status 
TPN. Free 7 ~ 
TPN. Partial I 
Hospital ..., () 
-
Home 6 ~ 
'Follow-up till 30 September 1992 
turned to hyperalimentation after discontinuation 
of immunosuppression because of viral encepha-
litis. Patient and graft survival was HS. Y per cent 
(RN) and 70 per cent (7/10). respectively. 
The postoperative courses. including Intensive 
Care Unit (lCU) stay. hospital stay. start of 
enteral feeding. and discontinuation of TPN. were 
more favourable for isolated graft recipients than 
those with the combined grafts. Methods of moni-
toring and treating graft rejection have been 
described elsewhere. >'.1>4 Of the 22 I!rafts. I Y ex-
perienced intestinal rejection. This (;ccurred at a 
1)0 per cent incidence (9/10) in the isolated grafts 
and at an incidence of 83 per cent (10112) when 
the intestine was part of a combination graft (dif-
ferences not significant). Of the 12 combined 
grafts. acute rejection was more frequent with the 
intestine (83 per cent. 10/12) than in the liver (42 
per cent. 5/12). The incidence of liver rejection 
in the combined graft was not different from that 
seen after liver transplantation alone. 
Synchronous graft rejection in the combined 
grafts (diagnosed by biopsy samples) of the small 
intestine and liver was seen on H occasions: this 
accounted for 17 per cent of 4H episodes of intes-
tinal rejection versus 31 per cent of 26 episodes 
of hepatic rejection. I n contrast. H3 per cent (401 
-lH) and 6<) per cent (IRI26) of the total episodes 
of acute rejection developed independent Iv in in-
testine and in liver. respectively. 
Conclusions 
Our experience has shown that clinical transplan-
tation of the intestine alone or with other abdom-
inal viscera is feasible under the improved 
immunosuppression that has been made possible 
with FK SOn. How much these procedures can 
improve the quality of life for patients who are 
destined to remain on TPN for life. or save 
patients from lethal TPN-related complications. 
will have to be determined by more cases and 
longer follow-up periods. Venous outflow from 
isolated intestinal grafts can be drained into the 
portal system and then through the native liver 
using a mesenteric piggy-back method. If the 
mesenteric piggy-back method is not possible. a 
mesenteric-systemic shunt can be used. probably 
without serious metabolic consequences. Al-
though hepatic tolerogenicity is a well-established 
concept. simultaneous liver transplantation is not 
necessary for successful intestinal transplantation 
in humans and it adds to the risk and magnitude of 
the treatment if the patient does not have hepatic 
failure. Thus. isolated intestinal transplantation 
should be chosen for patients who are destined to 
be on TPN for life. but who still have normal liver 
function. Combined intestine and liver transplan-
tation is reserved for those patients who need an 
intestine and have liver failure as a complication 
of TPN or inborn hepatic disorders. Multivisceral 
transplantation is reserved for special indications. 
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